|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Predix Pharmaceuticals Announces Findings From Preclinical Cognition Studies At The 10th International Conference On Alzheimer's Disease
7/18/2006 12:39:21 PM
LEXINGTON, Mass.--(BUSINESS WIRE)--July 18, 2006--Predix Pharmaceuticals, which recently announced a definitive agreement to merge with EPIX Pharmaceuticals (NASDAQ: EPIX - News), announced today that preclinical data from studies in Alzheimer's disease with PRX-03140, a highly selective, proprietary serotonin 4 (5-HT4) receptor agonist, will be featured in an oral presentation at the 10th International Conference on Alzheimer's Disease in Madrid, Spain from July 15-20, 2006. The Conference, part of the Alzheimer's Association research program, brings together more than 5,000 researchers to share information and resources on the etiology, pathology and treatment of Alzheimer's disease and related disorders.
|
|
|
|
|
|
|
|
|
|
|